ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/23/2023
Back to search
Official data from USPTO
AGILE CLINICAL RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AGILE CLINICAL RESEARCH
ST13
US500000077671298Class
42
Filing
77671298
Registration
3724768
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
08/23/2023
Trademark type
Word
Nice classes
42
Filing date
02/16/2009
Registration date
12/15/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/18/2020
Last transaction
11/28/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
01/09/2009
First use in commerce
01/09/2009
Drawing code
4
Owner type
16
Owner location
MORRISVILLE, NC, US
Examiner
MARCY, AMY ALFIERI
Law office
L90
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
PREMIER RESEARCH INTERNATIONAL LLC
HEALTH DECISIONS, INC.
Rosenberg, Michael
Representatives
Robert P. Parker Rothwell, Figg, Ernst & Manbeck, PC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Basic and clinical research in the field of respiratory science and medicine; Medical and scientific researchconducting clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Remote diagnosis of medical diagnostic imagingclinical and biomedical equipment for determining the need for repair
Publications
History of USPTO decisions and trademark events.
37 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/28/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/28/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/28/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/28/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/28/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/18/2020
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/18/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/18/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/18/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
12/04/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/15/2018
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/20/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/20/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/20/2016
E815
TEAS SECTION 8 & 15 RECEIVED
12/15/2015
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/16/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/08/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
12/15/2009
PUBO
PUBLISHED FOR OPPOSITION
09/29/2009
NPUB
NOTICE OF PUBLICATION
09/09/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/25/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/25/2009
XAEC
EXAMINER'S AMENDMENT ENTERED
08/25/2009
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/25/2009
GNEA
EXAMINERS AMENDMENT E-MAILED
08/25/2009
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/25/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/03/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/03/2009
ALIE
ASSIGNED TO LIE
08/03/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/17/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/07/2009
GNRT
NON-FINAL ACTION E-MAILED
05/07/2009
CNRT
NON-FINAL ACTION WRITTEN
05/07/2009
DOCK
ASSIGNED TO EXAMINER
05/06/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/19/2009
NWAP
NEW APPLICATION ENTERED
02/19/2009
Continuous trademark protection
Get notified about every new filing that threatens AGILE CLINICAL RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.